Medicaid Reimbursement for Oral Direct Antiviral Agents for the Treatment of Chronic Hepatitis C

Affiliations

¹ Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
² Yale Liver Center, Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

Kohtaro Ooka et al. Am J Gastroenterol. 2017 Jun.

. 2017 Jun;112(6):828-832.

doi: 10.1038/ajg.2017.87. Epub 2017 Apr 4.

¹ Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
² Yale Liver Center, Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

No abstract available

Comment in

Cost-Effective but Unaffordable and Unequal Hepatitis C Treatment in the US.
Liu X, Shen JJ, Lee JL, Yoo JW. Liu X, et al. Am J Gastroenterol. 2017 Nov;112(11):1749. doi: 10.1038/ajg.2017.210. Am J Gastroenterol. 2017. PMID: 29109499 No abstract available.
Response to Liu et al.
Ooka K, Connolly JJ, Lim JK. Ooka K, et al. Am J Gastroenterol. 2017 Nov;112(11):1749-1750. doi: 10.1038/ajg.2017.292. Am J Gastroenterol. 2017. PMID: 29109505 No abstract available.